日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Cancer burden and risk factors among women with HIV: a multi-regional study from the D:A:D and RESPOND cohort collaborations

HIV感染女性的癌症负担和风险因素：来自D:A:D和RESPOND队列合作的多区域研究

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103739
Han, Win Min; Neesgaard, Bastian; Knappik, Michael; Cavassini, Matthias; Abela, Irene A; Timiryasova, Alisa; Greenberg, Lauren; Martin, Charlotte; Mussini, Cristina; Wit, Ferdinand; Sabin, Caroline; Castagna, Antonella; Abutidze, Akaki; El-Sadr, Wafaa; Bonnet, Fabrice; Sarcletti, Mario; Carlander, Christina; Hachfeld, Anna; Weis, Nina; Vannappagari, Vani; Rogatto, Felipe P; Young, Lital A; Hosein, Sean R; Ryom, Lene; Petoumenos, Kathy
肿瘤
肿瘤免疫
HIV
炎症/感染
微生物学
发表日期：2026
文献求助 收藏

Characteristics and Clinical Predictors of Chlamydia trachomatis Infections Sustained by LGV Serovars Among Men Who Have Sex with Men

男男性行为者中由LGV血清型引起的沙眼衣原体感染的特征和临床预测因素

期刊:Microorganisms
影响因子:4.2
doi:10.3390/microorganisms14020262
Siribelli, Alessia; Raccagni, Angelo Roberto; Diotallevi, Sara; Lolatto, Riccardo; Alberton, Francesca; Messina, Emanuela; Sampaolo, Michela; Clementi, Nicola; Burioni, Roberto; Castagna, Antonella; Nozza, Silvia
炎症/感染
发表日期：2026
文献求助 收藏

The Role of Immune Dysregulation Markers in Cardiovascular Risk of People Living with HIV: Association Among Intima Media Changes, CD4/CD8 Ratio, and CD4+ Cell Count Nadir

免疫失调标志物在艾滋病毒感染者心血管风险中的作用：内膜中层变化、CD4/CD8 比值和 CD4+ 细胞计数最低值之间的关联

期刊:Viruses-Basel
影响因子:3.5
doi:10.3390/v18030383
Ceccarelli, Manuela; Ricci, Elena Delfina; Muccini, Camilla; Galli, Laura; Ferrara, Sergio; Tartaglia, Alessandra; Celesia, Benedetto Maurizio; Manzillo, Elio; Guida, Alessandra; Di Filippo, Giovanni; Basile, Rosa; Castagna, Antonella; Maggi, Paolo
T细胞
HIV
炎症/感染
CD8
微生物学
细胞生物学
CD4
免疫/内分泌
发表日期：2026
文献求助 收藏

Significant Impact of Previous Major Cardiovascular Events (MACEs) and Viremia on Risk of New MACEs in People Living with HIV on Antiretroviral Therapy

既往重大心血管事件（MACE）和病毒血症对接受抗逆转录病毒治疗的HIV感染者发生新发MACE风险的显著影响

期刊:Medicines
影响因子:
doi:10.3390/medicines13010004
Candela, Caterina; Siribelli, Alessia; Clemente, Tommaso; Lolatto, Riccardo; Bellomo, Michele; Stabile, Vincenzo; Hasson, Hamid; Spagnuolo, Vincenzo; Castagna, Antonella; Nozza, Silvia; Muccini, Camilla
HIV
炎症/感染
微生物学
发表日期：2026
文献求助 收藏

Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV

福斯特沙韦可降低接受过大量治疗的 HIV 感染者体内抗 gp120 CD4 诱导抗体的水平

期刊:Journal of Infectious Diseases
影响因子:
doi:10.1093/infdis/jiaf461
Benlarbi, Mehdi; Richard, Jonathan; Clemente, Tommaso; Bourassa, Catherine; Tolbert, William D; Prakash, Manyu; Chandravanshi, Monika; Clark, Andrew; Pazgier, Marzena; Durand, Madeleine; Castagna, Antonella; Finzi, Andrés
T细胞
HIV
炎症/感染
微生物学
CD4
发表日期：2026
文献求助 收藏

Age and viral replication, not vertical HIV acquisition, drive inflammation and T-cell dysfunction in heavily treatment experienced: data from the Prestigio Registry

在接受过大量治疗的患者中，年龄和病毒复制而非HIV垂直传播才是炎症和T细胞功能障碍的主要驱动因素：来自Prestigio注册研究的数据

期刊:AIDS
影响因子:
doi:10.1097/QAD.0000000000004415
Bono, Valeria; Tincati, Camilla; Augello, Matteo; Rovito, Roberta; Spagnuolo, Vincenzo; Galli, Laura; di Biagio, Antonio; Garlassi, Elisa; Moioli, Maria Cristina; Focà, Emanuele; Castagna, Antonella; Marchetti, Giulia
炎症
T细胞
HIV
炎症/感染
微生物学
T细胞
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation

病毒学抑制的 HIV 感染者改用双药方案与继续使用三药方案相比，发生临床事件的风险：一项目标试验模拟研究

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103368
Mussini, Cristina; Giacomelli, Andrea; Quiros-Roldan, Eugenia; Mazzotta, Valentina; Di Biagio, Antonio; De Vito, Andrea; Costantini, Andrea; D'Ettorre, Gabriella; Giacometti, Andrea; Vergori, Alessandra; Tavelli, Alessandro; Malagnino, Vincenzo; Castagna, Antonella; Chester, Johanna; Antinori, Andrea; d'Arminio Monforte, Antonella; Cozzi-Lepri, Alessandro
HIV
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Mortality using raltegravir versus other integrase strand-transfer inhibitors in people with HIV in Europe and Australia: a prospective multicentre study

在欧洲和澳大利亚，一项前瞻性多中心研究比较了使用拉替拉韦与其他整合酶链转移抑制剂治疗HIV感染者的死亡率：一项针对HIV感染者的前瞻性研究

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103521
Tusch, Erich; Ryom, Lene; Hoffmann, Christian; Degen, Olaf; Zangerle, Robert; Günthard, Huldrych F; Wit, Ferdinand; Mussini, Cristina; Castagna, Antonella; Martin, Charlotte; Giacomelli, Andrea; Vehreschild, Jörg Janne; Begovac, Josip; Vannappagari, Vani; Rooney, Jim; Dos Santos Mendes, Sofia; Tallada, Joan; Kowalska, Justyna; Wallner, Elmar; Kusejko, Katharina; Jaschinski, Nadine; Lundgren, Jens; Peters, Lars; Reekie, Joanne
HIV
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Efficacy and safety of the HIV-1 maturation inhibitor GSK3640254 plus two NRTIs in adults naive to antiretroviral therapy (DOMINO): 24-week results from a randomised phase 2b study

HIV-1成熟抑制剂GSK3640254联合两种核苷类逆转录酶抑制剂治疗未接受过抗逆转录病毒治疗的成年患者的疗效和安全性（DOMINO）：一项随机2b期研究的24周结果

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103567
Joshi, Samit R; Cordova, Ezequiel; Mitha, Essack; Castagna, Antonella; Ramgopal, Moti; Llibre, Josep M; Potthoff, Anja; Chernova, Oksana E; Nuñez, Sebastian A; Man, Choy; Jeffrey, Jerry L; Fishman, Cindy; Oyee, James; Joshi, Aditya; Zhang, Ying; Bainbridge, Veronica; Wynne, Brian; Lataillade, Max
HIV
GSK3
微生物学
发表日期：2025
文献求助 收藏

Efficacy and safety of the HIV-1 maturation inhibitor GSK3640254 plus dolutegravir as a two-drug regimen in adults naive to antiretroviral therapy (DYNAMIC): 24-week results from a randomised phase 2b study

在未接受过抗逆转录病毒治疗的成人患者中，HIV-1成熟抑制剂GSK3640254联合多替拉韦作为双药方案的疗效和安全性（DYNAMIC）：一项随机2b期研究的24周结果

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103566
Joshi, Samit R; Masiá, Mar; Mitha, Essack; Castagna, Antonella; Cordova, Ezequiel; Ramgopal, Moti; Gaudion, Alison; Karthika, Supriya; Oyee, James; Bainbridge, Veronica; Wynne, Brian; Lataillade, Max
HIV
GSK3
微生物学
发表日期：2025
文献求助 收藏